NDC 0781-3289-91 - Clindamycin in 5 Percent Dextrose
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3289
- Requested NDC
- 0781-3289-91
- Package NDCs from labels
- 0781-3289-91, 0781-3289-09
- Manufacturer
- Sandoz Inc
- Effective date
- 2026-03-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Clindamycin in 5 Percent Dextrose - Sandoz Inc | Sandoz Inc | 2026-03-02 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0781-3289-09 | Clindamycin in 5 Percent Dextrose | 24 in 1 CARTON | INJECTION, SOLUTION | 24 | 13 | |
| 0781-3289-91 | Clindamycin in 5 Percent Dextrose | 50 mL in 1 BAG | INJECTION, SOLUTION | 50 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3289-09 | ML - Milliliter | 0781-3289 | cacd9329-2e9e-4849-89cb-8140463e71da | 1 | 2013-03-03 |
| 0781-3289-91 | ML - Milliliter | 0781-3289 | 09b22340-ec4e-4be6-a0da-b7f038b9049c | 1 | 2013-09-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CLINDAMYCIN | ACTIVE INGREDIENT | 3U02EL437C | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 3 | |
| CLINDAMYCIN | ACTIVE MOIETY | 3U02EL437C | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 3 | |
| DEXTROSE MONOHYDRATE | INACTIVE INGREDIENT | LX22YL083G | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 3 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 3 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 3 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | CLINDAMYCIN IN 5 PERCENT DEXTROSE INJECTION, SOLUTION [SANDOZ INC] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dextrose | DEXTROSE MONOHYDRATE | Henry Schein, Inc. | 8cf6943f-16e8-4521-863c-09bb0b55e2a9 | 2026-09-09 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | REMEDYREPACK INC. | b8b77421-d687-45aa-82f6-d49bce644c10 | 2026-08-31 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-08-18 | Warnings, Adverse reactions | LX22YL083G |
| Cleocin Phosphate | CLINDAMYCIN PHOSPHATE | Pharmacia & Upjohn Company LLC | 05a75685-0af5-407c-ac57-e380c882b49d | 2026-07-29 | Boxed warning, Warnings, Adverse reactions | 309336 309339 309335 |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 4ed365da-4e62-4329-c1b9-c197ab4fb6e1 | 2026-07-13 | Warnings, Adverse reactions | LX22YL083G |
| Infant Dextrose | DEXTROSE | Henry Schein, Inc. | ce71d929-d11e-444c-bd45-e025d5172057 | 2026-07-13 | Warnings, Adverse reactions | LX22YL083G |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | LX22YL083G | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | LX22YL083G | |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 672264e3-9709-4bba-2a9d-12bf70c7396a | 2026-06-24 | Warnings, Adverse reactions | LX22YL083G |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd. | 395aec48-198a-4aed-8e38-7accfb3232f9 | 2026-06-15 | Warnings, Adverse reactions | LX22YL083G |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5423bde6-3e31-38b0-e063-6294a90afb2d | 2026-06-13 | Warnings | QTT17582CB |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | BM Private Limited | 540d11e3-e4a1-0ca2-e063-6394a90a3c26 | 2026-06-12 | Warnings | QTT17582CB |
| DEXTROSE | DEXTROSE MONOHYDRATE | Baxter Healthcare Corporation | 3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 | 2026-06-11 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose | DEXTROSE MONOHYDRATE | Hospira, Inc. | 10e98cb0-31a5-4ad1-3eaa-aa4af387a42d | 2026-06-02 | Warnings, Adverse reactions | LX22YL083G |
| ACD A | CITRIC ACID MONOHYDRATE, DEXTROSE MONOHYDRATE, AND TRISODIUM CITRATE DIHYDRATE | Terumo BCT, Ltd | 8e255bc7-a120-460a-a32d-43931f8115de | 2026-05-21 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.